Child death related to insulin omission by mother

S Mimasaka1, M Funayama, J Azumi

  • 1Department of Legal Medicine, Sapporo Medical University, School of Medicine, S. 1, W. 17, Chuo-ku, Sapporo 060-8556, Japan.

Insights

A child with insulin-dependent diabetes mellitus died due to poor glycemic control and likely neglect. Autopsy revealed ketoacidosis and liver abnormalities, suggesting a tragic case of child abuse.

Area of Science:

  • Pediatric Endocrinology
  • Forensic Pathology
  • Child Welfare

Background:

  • A 4-year-old child with a 3-year history of insulin-dependent diabetes mellitus (IDDM) presented with persistently poor glycemic control.
  • The child had multiple hospital admissions and monthly clinic visits, indicating ongoing medical management challenges.

Purpose of the Study:

  • To investigate the circumstances and pathological findings in a fatal case of pediatric IDDM potentially linked to neglect.
  • To determine the contributing factors to the child's death and assess the role of parental care and disease management.

Main Methods:

  • Autopsy examination to identify pathological changes.
  • Laboratory analysis of vitreous fluid for glucose and ketone levels.
  • Review of the child's medical history and the circumstances surrounding her death.

Main Results:

  • Autopsy revealed a fatty liver and absence of beta cells in pancreatic islets.
  • Laboratory findings included ketoacidosis, ketonuria, glycosuria, and elevated vitreous glucose and ketones.
  • Evidence suggested the mother's omission of insulin injections and general neglect, with the mother found intoxicated at the time of discovery.

Conclusions:

  • The case highlights a fatal outcome of poorly controlled pediatric IDDM, strongly associated with severe parental neglect and potential child abuse.
  • This case underscores the critical importance of consistent insulin therapy, diligent glycemic monitoring, and adequate parental supervision in managing childhood diabetes.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...